SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced that a total of nine...

Glenn Stevens, CEO of GAIN Capital Holdings, Inc. (NYSE: GCAP) ("GAIN" or "the Company") provides business update while presenting today at the Sandler O'Neill Global Exchange and Brokerage...

ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics (Nasdaq: KOOL), and a market leader in automated cellular processing, today announced that it will participate in and exhibit...

Cryoport, Inc. (Nasdaq: CYRX) (Nasdaq: CYRXW) (or the "Company"), the world's leading temperature-controlled supply chain company dedicated to the life sciences industry, today announced its Chief...

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Henry Fuchs, M.D., President, Worldwide Research & Development, will present at the Goldman Sachs 40th Annual Global Healthcare...